Clinical trial
Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and…
NCT00223990 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00223990 |
|---|---|
| Title | Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine |
| Official title | A Dbl-blind,Randomized,Controlled,Phase IIb Field Trial in 12-47 Month-old Children in Western Kenya to Eval the Efficacy,Safety and Immunogenicity of the FMP1/AS02A Malaria Vaccine vs Rabies Vaccine |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | The PATH Malaria Vaccine Initiative (MVI) United States Agency for International Development (USAID) U.S. Fed GlaxoSmithKline Industry Kenya Medical Research Institute Walter Reed Army Institute of… |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Biological |
| Interventions | FMP1/AS02A, RabAvert |
| Enrollment | 400 |
| Start date | Apr 8, 2005 |
| Primary completion | Apr 26, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 12, 2021 |
| Countries | Kenya |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: